Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic Disorders
Clinical trial NCT00189917 · COMPLETED
Trial details
- NCT number
- NCT00189917
- Sponsor
- Bavarian Nordic
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2005-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.